Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Germinal center B cells are a specialized population of B lymphocytes that transiently reside in organized structures (germinal centers) within the follicles of secondary lymphoid organs (lymph nodes, spleen, Peyer's patches)[1][2][4]. Upon antigen stimulation and help from T follicular helper cells, these B cells undergo rapid proliferation, somatic hypermutation, and affinity-based selection, leading to the generation of high-affinity antibody-secreting plasma cells and memory B cells. The germinal center reaction is anatomically and functionally divided into a “dark zone” (site of proliferation and mutation—centroblasts) and a “light zone” (site of selection—centrocytes)[1][2][3]. Germinal center B cells are essential for effective long-term immunity, but aberrations in their development or selection can result in lymphomas or autoimmunity[1][2][4][5][6]. This entry is not a conventional therapeutic target but rather a critical immune cell population with substantial biological and pathological importance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Germinal center B cell.